96 related articles for article (PubMed ID: 26713365)
21. Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis.
Edovitsky E; Elkin M; Zcharia E; Peretz T; Vlodavsky I
J Natl Cancer Inst; 2004 Aug; 96(16):1219-30. PubMed ID: 15316057
[TBL] [Abstract][Full Text] [Related]
22. [Human heparanase: roles in invasion and metastasis of cancer].
Gohji K; Katsuoka Y; Okamoto M; Kamidono S; Kitazawa S; Toyoshima M; Dong J; Nakajima M
Hinyokika Kiyo; 2000 Oct; 46(10):757-62. PubMed ID: 11215206
[TBL] [Abstract][Full Text] [Related]
23. Structural requirements for inhibition of melanoma lung colonization by heparanase inhibiting species of heparin.
Bitan M; Mohsen M; Levi E; Wygoda MR; Miao HQ; Lider O; Svahn CM; Ekre HP; Ishai-Michaeli R; Bar-Shavit R
Isr J Med Sci; 1995; 31(2-3):106-18. PubMed ID: 7744578
[TBL] [Abstract][Full Text] [Related]
24. Heparanase, heparin and the coagulation system in cancer progression.
Vlodavsky I; Ilan N; Nadir Y; Brenner B; Katz BZ; Naggi A; Torri G; Casu B; Sasisekharan R
Thromb Res; 2007; 120 Suppl 2():S112-20. PubMed ID: 18023704
[TBL] [Abstract][Full Text] [Related]
25. Alteration of endothelial proteoglycan and heparanase gene expression by high glucose, insulin and heparin.
Han J; Hiebert LM
Vascul Pharmacol; 2013; 59(3-4):112-8. PubMed ID: 23939434
[TBL] [Abstract][Full Text] [Related]
26. Versatile role of heparanase in inflammation.
Goldberg R; Meirovitz A; Hirshoren N; Bulvik R; Binder A; Rubinstein AM; Elkin M
Matrix Biol; 2013 Jun; 32(5):234-240. PubMed ID: 23499528
[TBL] [Abstract][Full Text] [Related]
27. Implications of heparan sulfate and heparanase in neuroinflammation.
Zhang X; Wang B; Li JP
Matrix Biol; 2014 Apr; 35():174-81. PubMed ID: 24398134
[TBL] [Abstract][Full Text] [Related]
28. Soluble antigen induces T lymphocytes to secrete an endoglycosidase that degrades the heparan sulfate moiety of subendothelial extracellular matrix.
Fridman R; Lider O; Naparstek Y; Fuks Z; Vlodavsky I; Cohen IR
J Cell Physiol; 1987 Jan; 130(1):85-92. PubMed ID: 2433294
[TBL] [Abstract][Full Text] [Related]
29. Heparanase expression in human colorectal cancer and its relationship to tumor angiogenesis, hematogenous metastasis, and prognosis.
Sato T; Yamaguchi A; Goi T; Hirono Y; Takeuchi K; Katayama K; Matsukawa S
J Surg Oncol; 2004 Sep; 87(4):174-81. PubMed ID: 15334632
[TBL] [Abstract][Full Text] [Related]
30. Heparanase activates the syndecan-syntenin-ALIX exosome pathway.
Roucourt B; Meeussen S; Bao J; Zimmermann P; David G
Cell Res; 2015 Apr; 25(4):412-28. PubMed ID: 25732677
[TBL] [Abstract][Full Text] [Related]
31. [Effects of anti-heparanase antibody on the growth and invasion of HCCLM6 human hepatocellular carcinoma cells].
Han XM; Wang HJ; Yang JM; Zhou YL; Tao HQ; Gao H; Ye ZY
Zhonghua Zhong Liu Za Zhi; 2009 Jan; 31(1):10-4. PubMed ID: 19538861
[TBL] [Abstract][Full Text] [Related]
32. Fatty acid-induced nuclear translocation of heparanase uncouples glucose metabolism in endothelial cells.
Wang F; Wang Y; Zhang D; Puthanveetil P; Johnson JD; Rodrigues B
Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):406-14. PubMed ID: 22116097
[TBL] [Abstract][Full Text] [Related]
33. [Role of eukaryotic initiation factor-4E (eIF-4E) in regulation of expression of NF-kappaB and its subsequent influence on transcription and activity of heparanase in human colon adenocarcinoma cell line].
Yang YJ; Zhang YL; Wang JD; Lai ZS; Wang QY; Cui HH
Ai Zheng; 2003 Oct; 22(10):1023-9. PubMed ID: 14558943
[TBL] [Abstract][Full Text] [Related]
34. Heparanase and cancer progression: New directions, new promises.
Arvatz G; Weissmann M; Ilan N; Vlodavsky I
Hum Vaccin Immunother; 2016 Sep; 12(9):2253-6. PubMed ID: 27054564
[TBL] [Abstract][Full Text] [Related]
35. A simple and rapid assay for heparanase activity using homogeneous time-resolved fluorescence.
Enomoto K; Okamoto H; Numata Y; Takemoto H
J Pharm Biomed Anal; 2006 Jun; 41(3):912-7. PubMed ID: 16495030
[TBL] [Abstract][Full Text] [Related]
36. Hypoxia increases heparanase-dependent tumor cell invasion, which can be inhibited by antiheparanase antibodies.
He X; Brenchley PE; Jayson GC; Hampson L; Davies J; Hampson IN
Cancer Res; 2004 Jun; 64(11):3928-33. PubMed ID: 15173004
[TBL] [Abstract][Full Text] [Related]
37. Co-expression of CD44v3 and heparanase is correlated with metastasis of human colon cancer.
Kuniyasu H; Chihara Y; Kubozoe T; Takahashi T
Int J Mol Med; 2002 Sep; 10(3):333-7. PubMed ID: 12165810
[TBL] [Abstract][Full Text] [Related]
38. Rofecoxib has different effects on chemokine production in colorectal cancer cells and tumor immune splenocytes.
Walmesley AJ; Zweiri J; Christmas SE; Watson AJ
J Immunother; 2007 Sep; 30(6):614-23. PubMed ID: 17667525
[TBL] [Abstract][Full Text] [Related]
39. Dissociation between mature phenotype and impaired transmigration in dendritic cells from heparanase-deficient mice.
Benhamron S; Reiner I; Zcharia E; Atallah M; Grau A; Vlodavsky I; Mevorach D
PLoS One; 2012; 7(5):e35602. PubMed ID: 22590508
[TBL] [Abstract][Full Text] [Related]
40. P-selectin- and heparanase-dependent antimetastatic activity of non-anticoagulant heparins.
Hostettler N; Naggi A; Torri G; Ishai-Michaeli R; Casu B; Vlodavsky I; Borsig L
FASEB J; 2007 Nov; 21(13):3562-72. PubMed ID: 17557930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]